BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2507129)

  • 1. Hypersensitivity to cell killing and faulty repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in human (ataxia-telangiectasia) fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R; Smith BP; Paterson MC
    Cancer Res; 1989 Oct; 49(20):5523-9. PubMed ID: 2507129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced bioreduction of 4-nitroquinoline 1-oxide by cultured ataxia telangiectasia cells.
    Mirzayans R; Sabour M; Paterson MC
    Carcinogenesis; 1988 Sep; 9(9):1711-5. PubMed ID: 3136948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential repair of 1-beta-D-arabinofuranosylcytosine-detectable sites in DNA of human fibroblasts exposed to ultraviolet light and 4-nitroquinoline 1-oxide.
    Mirzayans R; Paterson MC
    Mutat Res; 1991 Jul; 255(1):57-65. PubMed ID: 1906130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and repair of DNA strand breaks and 1-beta-D-arabinofuranosylcytosine-detectable sites in 40-75 kVp X-irradiated compared to 60Co gamma-irradiated human cell lines.
    Mirzayans R; Waters R; Paterson MC
    Radiat Res; 1988 Apr; 114(1):168-85. PubMed ID: 3353503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation between p53 protein levels and DNA repair efficiency in human fibroblast strains treated with 4-nitroquinoline 1-oxide: evidence that lesions other than DNA strand breaks trigger the p53 response.
    Mirzayans R; Bashir S; Murray D; Paterson MC
    Carcinogenesis; 1999 Jun; 20(6):941-6. PubMed ID: 10357771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between hypersensitivity to cell killing and impaired inhibition of DNA synthesis in ataxia telangiectasia fibroblasts treated with 4-nitroquinoline 1-oxide.
    Mirzayans R; Paterson MC
    Carcinogenesis; 1991 Jan; 12(1):19-24. PubMed ID: 1899054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered repair of excisable 4-nitroquinoline-1-oxide adducts in a larger fraction of genomic DNA of xeroderma pigmentosum complementation group C cells.
    Fujiwara Y
    Carcinogenesis; 1989 Oct; 10(10):1777-85. PubMed ID: 2507185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective repair of a class of 4NQO-induced alkali-labile DNA lesions in xeroderma pigmentosum complementation group A fibroblasts.
    Mirzayans R; Paterson MC; Waters R
    Carcinogenesis; 1985 Apr; 6(4):555-9. PubMed ID: 3921271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response to DNA damage induced by 4-nitroquinoline-1-oxide or its 3-methyl derivative in xeroderma pigmentosum fibroblasts belonging to different complementation groups: evidence for different epistasis groups involved in the repair of large adducts in human DNA.
    Edwards S; Fielding S; Waters R
    Carcinogenesis; 1987 Aug; 8(8):1071-5. PubMed ID: 3111741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaline sucrose sedimentation analysis as an indicator of repair capability of xeroderma pigmentosum fibroblasts for 4-nitroquinoline-1-oxide damage.
    Walker IG
    Carcinogenesis; 1981; 2(8):691-5. PubMed ID: 6793257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective DNA repair and increased lethality in ataxia telangiectasia cells exposed to 4-nitroquinoline-1-oxide.
    Smith PJ; Paterson MC
    Nature; 1980 Oct; 287(5784):747-9. PubMed ID: 6776412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predominant role for DNA damage in etoposide-induced cytotoxicity and cell cycle perturbation in human SV40-transformed fibroblasts.
    Smith PJ; Anderson CO; Watson JV
    Cancer Res; 1986 Nov; 46(11):5641-5. PubMed ID: 3019531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal regulation of DNA replication and increased lethality in ataxia telangiectasia cells exposed to carcinogenic agents.
    Jaspers NG; de Wit J; Regulski MR; Bootsma D
    Cancer Res; 1982 Jan; 42(1):335-41. PubMed ID: 6172195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylmethanesulfonate-induced DNA damage and its repair in cultured human fibroblasts: normal rates of induction and removal of alkali-labile sites in xeroderma pigmentosum (group A) cells.
    Mirzayans R; Liuzzi M; Paterson MC
    Carcinogenesis; 1988 Dec; 9(12):2257-63. PubMed ID: 3191570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of in vivo DNA repair synthesis in mouse liver and lung induced by treatment with benzo(a)pyrene or 4-nitroquinoline 1-oxide.
    Kulkarni MS; Angerman-Stewart J; Anderson MW
    Cancer Res; 1984 Apr; 44(4):1547-50. PubMed ID: 6322980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between DNA strand breakage and p53 protein levels in human fibroblast strains exposed to ultraviolet lights.
    Enns L; Murray D; Mirzayans R
    Photochem Photobiol; 2000 Oct; 72(4):562-8. PubMed ID: 11045730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
    Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
    Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity of ataxia telangiectasia skin fibroblasts to DNA alkylating agents.
    Barfknecht TR; Little JB
    Mutat Res; 1982 Jun; 94(2):369-82. PubMed ID: 6810166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair of chromosome damage induced by X-irradiation during G2 phase in a line of normal human fibroblasts and its malignant derivative.
    Parshad R; Gantt R; Sanford KK; Jones GM; Tarone RE
    J Natl Cancer Inst; 1982 Aug; 69(2):409-14. PubMed ID: 6810003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO.
    Kim MM; Glazer CA; Mambo E; Chatterjee A; Zhao M; Sidransky D; Califano JA
    Oral Oncol; 2006 Feb; 42(2):201-7. PubMed ID: 16266817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.